Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $0.93 $650,790 - $1.14 Million
-1,227,906 Reduced 14.15%
7,452,361 $4.32 Million
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $7.72 Million - $14 Million
-12,249,337 Reduced 58.53%
8,680,267 $7.2 Million
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $1.48 Million - $2.48 Million
1,319,324 Added 6.73%
20,929,604 $23.7 Million
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $8.57 Million - $13.3 Million
-6,543,847 Reduced 25.02%
19,610,280 $31.4 Million
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $5.15 Million - $10.5 Million
3,550,477 Added 15.71%
26,154,127 $39.8 Million
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $4.6 Million - $7.4 Million
2,277,707 Added 11.21%
22,603,650 $54.2 Million
Q3 2022

Nov 15, 2022

SELL
$1.96 - $3.14 $5.72 Million - $9.16 Million
-2,917,318 Reduced 12.55%
20,325,943 $41.7 Million
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $7.13 Million - $14.5 Million
5,484,637 Added 30.88%
23,243,261 $45.1 Million
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $8.02 Million - $11.8 Million
-3,412,226 Reduced 16.12%
17,758,624 $43.7 Million
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $25.9 Million - $50.8 Million
8,857,832 Added 71.94%
21,170,850 $68.2 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $6.45 Million - $8.59 Million
1,296,184 Added 11.77%
12,313,018 $64.6 Million
Q2 2021

Aug 16, 2021

SELL
$2.56 - $5.49 $4.25 Million - $9.12 Million
-1,660,586 Reduced 13.1%
11,016,834 $60.5 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $6.39 Million - $12.5 Million
2,376,889 Added 23.08%
12,677,420 $34.5 Million
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $11.3 Million - $16.1 Million
3,575,293 Added 53.16%
10,300,531 $32.8 Million
Q3 2020

Nov 10, 2020

BUY
$2.98 - $5.2 $311,436 - $543,446
104,509 Added 1.58%
6,725,238 $26.9 Million
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $6.3 Million - $11.7 Million
2,752,124 Added 71.14%
6,620,729 $26 Million
Q1 2020

May 11, 2020

BUY
$1.92 - $4.39 $7.43 Million - $17 Million
3,868,605 New
3,868,605 $9.48 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.